Can-Fite Implements Interim Analysis for its Phase III Psoriasis Trial with Data Expected Q4 2020
30 Mar 2020
Business Wire
Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address in